AMPLIFICATION AND EXPRESSION OF THE C-MYC ONCOGENE IN HUMAN-LUNG CANCER CELL-LINES
AMPLIFICATION AND EXPRESSION OF THE C-MYC ONCOGENE IN HUMAN-LUNG CANCER CELL-LINES
复制标题
DOI:
10.1038/306194a0
复制
发表时间:
1983-01-01
期刊:
影响因子:
64.8
通讯作者:
MINNA, JD
中科院分区:
文献类型:
--
作者:
LITTLE, CD;NAU, MM;MINNA, JD
Genetic changes involving the c-myconcogene have been observed in human tumours. In particular, the c-mycgene is translocated in Burkitt's lymphoma1–3and is amplified in the human promyelocytic leukaemia cell line. HL-60, which contains double minute chromosomes (DMs)4,5. More recently, an amplified c-mycgene has been positioned on a chromosomal homogeneous staining region (HSR) in a human colon cancer cell line, COLO 320, with neuroendocrine properties6. Furthermore, c-mycis expressed in increased amounts in some human tumour lines, and in some cases, human small cell lung cancers (SCLC) contain DMs and HSRs7,8. These findings prompted us to study the c-mycgene and its RNA expression in a series of human lung cancer cell lines. We now report amplification and expression of the c-myconcogene in a system other than B-cell lymphomas9, namely human lung cancer. Of 18 human lung cancer cell lines tested, 8 showed an amplified 12.5-kilobase (kb)EcoRI c-mycDNA band. Of particular interest are five SCLC lines with a high degree of c-mycDNA amplification (20–76-fold) and greatly increased levels of c-mycRNA. All five lines reside in the variant class of SCLC (SCLC-V) characterized by altered morphology, lack of expression of some SCLC-dlfferentlated functions and more malignant behaviour than pure SCLC10,11. Three of the five lines which have been karyotyped also contain DMs or HSRs. The finding of a greatly amplified c-mycgene in all cell lines of the SCLC-V class examined strongly suggests a role for the c-mycgene in the phenotypic conversion and malignant behaviour of human lung cancer.